Famotidine Drug Study

Friday, February 20, 2009

In making a Drug Study, the following elements must be present: Generic Name and the Brand name (not all brands, just the brand used by the patient), Action, Indication, Pregnancy Category, Drug Classification, and Contraindication, Adverse Effect, Drug interaction and Nursing Consideration/Intervention…. Most clinical instructors preferred this to be in a long bond paper in printed or handwritten with paper in landscape.

Famotidine

Brand Name: Apo-Famotidine (CAN), Novo-Famotidine (CAN), Pepcid, Pepcid AC, Pepcid RPD

Pregnancy Category B

Drug class: Histamine 2 (H2) antagonist


Therapeutic actions

Competitively blocks the action of histamine at the histamine (H2) receptors of the parietal cells of the stomach; inhibits basal gastric acid secretion and chemically induced gastric acid secretion.


Indications

· Short-term treatment and maintenance of duodenal ulcer

· Short-term treatment of benign gastric ulcer

· Treatment of pathologic hypersecretory conditions

· Short-term treatment of gastroesophageal reflux disease (GERD), esophagitis due to GERD

· Relief of symptoms of heartburn, acid indigestion, sour stomach (OTC)


Contraindications

· Allergy to famotidine; renal failure; pregnancy; lactation.


Adverse effects

Headache, malaise, dizziness, somnolence, insomnia, Rash, Diarrhea, constipation, anorexia, abdominal pain, Muscle cramp, increase in total bilirubin, sexual impotence


Nursing considerations

· Administer drug at bedtime.

· Decrease doses with renal failure.

· Arrange for administration of concurrent antacid therapy to relieve pain.


0 comments:

Post a Comment